A multicenter real-life study on the effect of flash glucose monitoring on glycemic control in patients with type 1 and type 2 diabetes

Diabetes Technology and Therapeutics

Volumn 19, Issue 9, 2017, Pages 533-539

  Anjana, Ranjit Mohan ^a   Kesavadev, Jothydev ^b   Neeta, Deshpande ^c   Tiwaskar, Mangesh ^d   Pradeepa, Rajendra ^a,b   Jebarani, Saravanan ^a   Thangamani, Suresh ^a   Sastry, Nadiminty Ganapathi ^a   Brijendra Kumar, Srivastava ^a   Ramu, Muthu ^a   Gupta, Pokal Prasanna Kumar ^a   Vignesh, Jayaprakash ^a   Chandru, Sundramoorthy ^a   Kayalvizhi, Sengottuvel ^a   Jagdish, Padoor Sethuraman ^a   Uthra, Subash Chandra Bose ^a   Lovelena, Munawar ^a   Jyoti, Sah ^a   Suguna Priya, Sengodan ^a   Kannan, Alagarsamy ^a   Mohan, Viswanathan ^a   Unnikrishnan, Ranjit ^a   more..

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b Jothydev's Diabetes and Research Center   (India)

^c Belgaum Diabetes Centre   (India)

^d Shilpa Medical Research Centre   (India)

Author keywords

Ambulatory glucose profile; Continuous glucose monitoring; Diabetes; Glycated hemoglobin; Glycemic control; Indians

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; GLUCOSE OXIDASE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; DISEASE DURATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADOLESCENT; AGED; AMBULATORY MONITORING; ANALYSIS; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION DRUG THERAPY; DIABETIC COMPLICATION; ELECTRONIC HEALTH RECORD; HYPERGLYCEMIA; HYPOGLYCEMIA; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; ELECTRONIC HEALTH RECORDS; FEMALE; FOLLOW-UP STUDIES; GLYCATED HEMOGLOBIN A; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INDIA; MALE; MIDDLE AGED; MONITORING, AMBULATORY; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 85047346855     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2017.0063     Document Type: Article

References (18)

1. American Diabetes Association: Standards of medical care in diabetes-2017. Abridged for primary care providers. Clin Diabetes 2017;35:5-26.
2. Suh S, Kim JH: Glycemic variability: How do we measure it and why is it important? Diabetes Metab J 2015;39:273-282.
3. Bailey T, Bode BW, Christiansen MP, et al.: The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther 2015;17:787-794.
4. Bonora B, Maran A, Ciciliot S, et al.: Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes. J Endocrinol Invest 2016;39:1391-1399.
5. Ji L, Guo X, Guo L, et al.: A Multicenter evaluation of the performance and usability of a novel glucose monitoring system in chinese adults with diabetes. J Diabetes Sci Technol 2017;11:290-295.
6. Rai S, Hulse A, Kumar P: Feasibility and acceptability of ambulatory glucose profile in children with type 1 diabetes mellitus: a pilot study. Indian J Endocrinol Metab 2016;20: 790-794.
7. Hulse A, Rai S, Prasanna Kumar KM: Evaluation of accuracy of ambulatory glucose profile in an outpatient setting in children with type 1diabetes. Indian J Endocrinol Metab 2016;20:643-647.
8. Distiller LA, Cranston I, Mazze R: First clinical experience with retrospective flash glucose monitoring (FGM) analysis in South Africa: characterizing glycemic control with ambulatory glucose profile. J Diabetes Sci Technol 2016;10: 1294-1302.
9. Haak T, Hanaire H, Ajjan R, et al.: Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2017;8:55-73.
10. Deepa M, Pradeepa R, Rema M, et al.: The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003;51:863-870.
11. Kalra S, Gupta Y: Ambulatory glucose profile: flash glucose monitoring. J Pak Med Assoc 2015;65:1360-1362.
12. RSSDI Clinical Practice Recommendations for Management of Type 2 diabetes Mellitus-2015. http://rssdi. in/new/pdf/ RSSDI%20Clinical%20Practice%20Recommendations%20 for%20Management%20of%20Type%202%20Diabetes%20 Mellitus-%202015. pdf (accessed March 20, 2017).
13. Mohan V, Jain S, Kesavadev J, et al.: Use of retrospective continuous glucose monitoring for optimizing management of type 2 diabetes in India. J Assoc Physicians India 2016; 64:16-21.
14. Dover AR, Stimson RH, Zammitt NN, et al.: Flash glucose monitoring improves outcomes in a type 1 diabetes clinic. J Diabetes Sci Technol. 2017;11:442-443.
15. Ish-Shalom M, Weinstein J, Raz I, et al.: Improvement in glucose control in difficult-to-control patients with diabetes using a novel flash glucose monitoring device. J Diabetes Sci Technol 2016;10:1412-1413.
16. Anjana RM, Shanthirani CS, Unnikrishnan R, et al.: Regularity of follow-up, glycemic burden, and risk for microvascular complications in patients with type 2 diabetes: a 9 year follow-up study. Acta Diabetol 2015;52:601-609.
17. Turner RC, Holman RR, Cull CA, et al.: Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853.
18. McKnight JA, Gibb FW: Flash glucose monitoring is associated with improved glycaemic control but use is largely limited to more affluent people in a UK diabetes centre. Diabet Med 2017;19. doi: 10. 1111/dme. 13315.